ClinVar Miner

Submissions for variant NM_181458.4(PAX3):c.540C>G (p.Ser180Arg)

gnomAD frequency: 0.00020  dbSNP: rs200679164
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000601148 SCV000711527 uncertain significance not specified 2016-06-02 criteria provided, single submitter clinical testing The p.Ser180Arg variant in PAX3 has not been previously reported in individuals with hearing loss or Waardenburg syndrome, but has been identified in 8/10406 Af rican chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadin stitute.org; dbSNP rs200679164). Although this variant has been seen in the gene ral population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation analyses do not provide strong s upport for or against an impact to the protein. In summary, the clinical signifi cance of the p.Ser180Arg variant is uncertain.
Fulgent Genetics, Fulgent Genetics RCV000765615 SCV000896939 uncertain significance Alveolar rhabdomyosarcoma; Waardenburg syndrome type 1; Craniofacial-deafness-hand syndrome; Waardenburg syndrome type 3 2018-10-31 criteria provided, single submitter clinical testing
Invitae RCV003718260 SCV004506925 likely benign not provided 2023-11-22 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.